Skip to content
10-Q

Quarterly Report

Arno Therapeutics, Inc

0001144204-16-134183

← back to feed
Filed
Nov 14, 2016 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2016 · Nov 9, 2016 49.35M sh
Long Term Debt Q3 2016 · Sep 30, 2016 $0
Long Term Debt Q3 2016 · Dec 31, 2015 $2.09M
Cash And Equivalents Q3 2016 · Sep 30, 2016 $2.12M
Cash And Equivalents Q3 2016 · Dec 31, 2015 $66.99K
Cash And Equivalents Q3 2016 · Sep 30, 2015 $123.27K
Cash And Equivalents Q3 2016 · Dec 31, 2014 $7.95M
Stockholders Equity Q3 2016 · Sep 30, 2016 −$5.71M
Stockholders Equity Q3 2016 · Dec 31, 2015 −$8.62M
Current Liabilities Q3 2016 · Sep 30, 2016 $1.53M
Current Liabilities Q3 2016 · Dec 31, 2015 $4.23M
Total Liabilities Q3 2016 · Sep 30, 2016 $8.07M
Total Liabilities Q3 2016 · Dec 31, 2015 $8.99M
Current Assets Q3 2016 · Sep 30, 2016 $2.33M
Current Assets Q3 2016 · Dec 31, 2015 $327.68K
Total Assets Q3 2016 · Sep 30, 2016 $2.36M
Total Assets Q3 2016 · Dec 31, 2015 $361.24K
Sga Expense Q3 2016 · Sep 30, 2016 $1.12M
Sga Expense Q3 2016 · Sep 30, 2016 $3.65M
Sga Expense Q3 2016 · Sep 30, 2015 $1.08M
Sga Expense Q3 2016 · Sep 30, 2015 $3.8M
Rd Expense Q3 2016 · Sep 30, 2016 $1.12M
Rd Expense Q3 2016 · Sep 30, 2016 $4.72M
Rd Expense Q3 2016 · Sep 30, 2015 $1.79M
Rd Expense Q3 2016 · Sep 30, 2015 $6.92M
Net Income Q3 2016 · Sep 30, 2016 −$3.85M
Net Income Q3 2016 · Sep 30, 2016 −$9.7M
Net Income Q3 2016 · Sep 30, 2015 −$679.31K
Net Income Q3 2016 · Sep 30, 2015 −$7.51M
Operating Income Q3 2016 · Sep 30, 2016 −$2.23M
Operating Income Q3 2016 · Sep 30, 2016 −$8.37M
Operating Income Q3 2016 · Sep 30, 2015 −$2.87M
Operating Income Q3 2016 · Sep 30, 2015 −$10.72M